JP Rindone, CK Mellen, M Goldenstein - Hospital Pharmacy, 2023 - europepmc.org
Background: The PARADIGM HF trial showed sacubitril/valsartan (SV) to be superior to
enalapril in patients with reduced ejection fraction (HFrEF). Since its publication, several …